HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beauty Supply Chain Hampered By ‘Post-COVID Hangover,’ Geopolitical, Climate Change Impacts

Executive Summary

The global beauty ingredient supply chain is functioning again after pandemic-related lockdowns and other disruptions, but companies are having to contend with regional challenges, geopolitical turmoil and the impacts of climate change, supply and distribution experts said at the IBA Supply Chain and Sustainability Summit.

You may also be interested in...



Cosmetic Ingredients That Could Be Hard To Get In 2023

Beauty and personal-care product manufacturers should expect continued supply chain issues in 2023, supplier execs said at the IBA Supply Chain and Sustainability Virtual Summit, highlighting a number of ingredients and materials that could face particular challenges.

CEOs Urge ‘Civility’ In Supply Chain Dealings; ‘We’re Going To Come Out Of This At Some Point’

Today’s global supply chain is trying, but there’s opportunity amid the frustrations for companies to strengthen vendor and customer relations that pay off down the road, according to contract manufacturing and consumer product CEOs speaking to HBW Insight.

Unilever Squelches Dr. Squatch Comparative Claims In NAD Forum; Advertiser Can Keep Its 'Sh*t List’

Dr. Squatch was able to substantiate that it uses “no harmful ingredients” as well as certain claims about avoiding a “Sh*t list” of ingredients, but agreed to modify other claims the National Advertising Division deemed falsely disparage competitor products, such as Unilever’s Dove personal-care brand.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel